|
UHRF1BP1L expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.015200E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.435900E-02 |
| Normal-vs-Stage2 |
4.737800E-01 |
| Normal-vs-Stage3 |
1.226010E-04 |
| Normal-vs-Stage4 |
9.002200E-03 |
| Stage1-vs-Stage2 |
7.567200E-01 |
| Stage1-vs-Stage3 |
1.587790E-02 |
| Stage1-vs-Stage4 |
2.116200E-01 |
| Stage2-vs-Stage3 |
8.041800E-02 |
| Stage2-vs-Stage4 |
3.068600E-01 |
| Stage3-vs-Stage4 |
4.582600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.197600E-03 |
| Normal-vs-AfricanAmerican |
4.62250000499154E-08 |
| Normal-vs-Asian |
1.570830E-01 |
| Caucasian-vs-AfricanAmerican |
7.84390000000412E-05 |
| Caucasian-vs-Asian |
8.288800E-01 |
| AfricanAmerican-vs-Asian |
1.820980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.316500E-03 |
| Normal-vs-Female |
5.998500E-03 |
| Male-vs-Female |
9.706000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.008230E-02 |
| Normal-vs-Age(41-60Yrs) |
3.193700E-02 |
| Normal-vs-Age(61-80Yrs) |
2.623700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.432370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.204630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.581350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.746600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.852600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.443800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.202600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.008170E-01 |
| Normal-vs-Grade 2 |
5.488100E-02 |
| Normal-vs-Grade 3 |
2.618000E-03 |
| Normal-vs-Grade 4 |
1.605590E-04 |
| Grade 1-vs-Grade 2 |
7.470800E-01 |
| Grade 1-vs-Grade 3 |
9.919600E-01 |
| Grade 1-vs-Grade 4 |
3.985800E-01 |
| Grade 2-vs-Grade 3 |
3.233400E-01 |
| Grade 2-vs-Grade 4 |
1.724000E-02 |
| Grade 3-vs-Grade 4 |
6.688400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.553400E-01 |
| Normal-vs-ccB subtype |
1.921670E-02 |
| ccA subtype-vs-ccB subtype |
1.305370E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.608200E-02 |
| Normal-vs-N1 |
5.273400E-01 |
| N0-vs-N1 |
9.661800E-01 |
|
|
